7.5m XT, page-21

First 21 Last

Share
Profile

Follow
Hottin

6,469 Posts.

349

23/07/17

23:12

Post #: 26032497
Share

Originally posted by kearneymaurice ↑

With a bit of luck the June 2017 quarterly cashflow report will be out by the end of the week. Given the board is planning the AGM in September, getting ready for the annual report to closely follow in early August.

The board has already reconfirmed the positive $500,000 (approx.) before tax profit result for FY2017. I have compared this result to the previously three financial years which was a loss of $233,222 in FY2014, a loss of $385,366 in FY2015 and a loss of $452,411 in FY2016. There was a growing trend of increased losses which was concerning. That has come to an abrupt end in a year of transition to outsource manufacturing in the USA while at the same time finding a new precursor supplier, introducing a global chemist network and commercialising the ZinXation range.

Comparing FY2017 against FY2016, there is a $950,000 turnaround. The doubters will tell you it’s just purely cost savings, they might even suggest to you that they are probably just one off savings that will not be repeated; I personally think that there is a bit more to it. The ten per cent increase in revenue is promising. We will find out soon what is going on with ZinXation. My only advice is if you are thinking of selling, perhaps wait until the reports are released and then make an informed decision.

Expand

Hello boys and girls, I just landed .
I agree Mr big holder! And please do not listen to the guy above, if you want to sell do call me I am happy to pay 2.4c for all your shares .
I expect good results for the 2017 and really good results for the 2018.

ANO Price at posting: 3.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

First 21 Last

Add ANO (ASX) to my watchlist

(20min delay)
Last 72.0¢		Change 0.000(0.00%)		Mkt cap ! $44.96M

Open	High	Low	Value	Volume
72.0¢	72.0¢	72.0¢	$187	260

Buyers (Bids)

No.	Vol.	Price($)
2	56798	72.0¢

Sellers (Offers)

Price($)	Vol.	No.
76.5¢	921	1

View Market Depth

No.	Vol.	Price($)
2	56798	0.720
1	425	0.705
1	455	0.655
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.765	921	1
0.790	500	1
0.800	26001	1
0.985	1000	1
1.050	15000	1

Last trade - 16.10pm 11/07/2024 (20 minute delay)

ANO (ASX) Chart

7.5m XT, page-21

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Canadian fieldwork yields multiple pegmatites for Trinex

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

7.5m XT, page-21

Top Stories

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Canadian fieldwork yields multiple pegmatites for Trinex

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News